18F-PSMA
Prostate-specific antigen
The action of the tracer 18F-PSMA is based on its ability to specifically identify and bind to prostate-specific membrane antigen (PSMA), the activity of which increases in most primary and metastatic lesions of the prostate gland.
The advantage of the tracer with 18F in its composition (in contrast to a similar tracer with 68Ga) is that the positrons emitted by the fluorine isotope have lower energy. This allows to reduce the "noise" of the image, improve contrast resolution and increase the probability of detecting small formations.
Advantages of the tracer
Other tracers
in which one of the hydroxyl groups is replaced
by the radioactive isotope fluorine-18.
It is possible to examine
almost the entire human body with the help of this tracer.
used in diagnosis in patients
with brain neoplasms.
Find out how
we produce the tracer
Delivery to PET/CT medical locations
Our own production sites are located in Ufa, Yelets, Stavropol,
Novosibirsk and Pavlovskaya town in Krasnodar Region.
Partners' production sites are in Balashikha, Chelyabinsk, Kazan.
Pharmaceuticals are supplied daily to more than 35 diagnostic centers.